| 期 |
栏目 |
标题 |
文件 |
| 卷 7, 编号 1 (2010) |
Articles |
Znachenie agonista imidazolinovykh retseptorov moksonidina v lechenii bol'nykh arterial'noy gipertoniey i metabolicheskim sindromom. Rezul'taty issledovaniya MERSY v Rossii |
|
| 卷 8, 编号 2 (2011) |
Articles |
Svyaz' chisla komponentovmetabolicheskogo sindromas rasprostranennost'yui vyrazhennost'yu porazheniyaorganov-misheney |
|
| 卷 10, 编号 4 (2013) |
Articles |
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District |
|
| 卷 10, 编号 4 (2013) |
Articles |
Coagulogic risk factors of heart disease in the adult population of Tomsk |
|
| 卷 11, 编号 1 (2014) |
Articles |
Hypertension treatment features in perimenopausal women |
(Rus)
|
| 卷 11, 编号 1 (2014) |
Articles |
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components |
(Rus)
|
| 卷 11, 编号 2 (2014) |
Articles |
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk |
(Rus)
|
| 卷 11, 编号 4 (2014) |
Articles |
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF |
(Rus)
|
| 卷 12, 编号 2 (2015) |
Articles |
Calcium channel blockers: more than 50 years on guard of health |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
The role of beta-blockers in the treatment of arterial hypertension: what do we know today |
(Rus)
|
| 卷 12, 编号 3 (2015) |
Articles |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
| 卷 12, 编号 1 (2015) |
Articles |
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach |
(Rus)
|
| 卷 13, 编号 3 (2016) |
Articles |
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan |
(Rus)
|
| 卷 13, 编号 3 (2016) |
Articles |
Control of cardiovascular risk in patients with diabetes |
(Rus)
|
| 卷 14, 编号 1 (2017) |
Articles |
Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study) |
(Rus)
|
| 卷 13, 编号 4 (2016) |
Articles |
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome |
(Rus)
|
| 卷 14, 编号 1 (2017) |
Articles |
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients |
(Rus)
|
| 卷 14, 编号 3 (2017) |
Articles |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
(Rus)
|
| 卷 15, 编号 1 (2018) |
Articles |
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines] |
(Rus)
|
| 卷 15, 编号 3 (2018) |
Articles |
Obesity as a predictor for cardiovascular disease development: role of localized fat depot |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Polypill" conception in modern cardiology |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients |
(Rus)
|
| 卷 15, 编号 4 (2018) |
Articles |
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity |
(Rus)
|
| 卷 6, 编号 4 (2009) |
Articles |
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA) |
|
| 卷 8, 编号 1 (2011) |
Articles |
Tyazhest' metabolicheskogo sindroma opredelyaetsya chislom ego komponentov. |
|
| 卷 8, 编号 3 (2011) |
Articles |
Vliyanie chisla odnovremennovstrechayushchikhsya komponentovmetabolicheskogo sindroma na tyazhest'arterial'noy gipertonii,rasprostranennost' i vyrazhennost'porazheniya organov-misheneyu dannykh bol'nykh |
|
| 卷 8, 编号 4 (2011) |
Articles |
Vliyanie stepeni narusheniy uglevodnogo obmena na tyazhest' arterial'noy gipertonii, rasprostranennost' i vyrazhennost' porazheniya organov-misheney u bol'nykh s metabolicheskim sindromom |
|
| 卷 16, 编号 1 (2019) |
Articles |
Diagnosis and treatment of arterial hypertension [Guidelines] |
(Rus)
|
